Dealing with the Unexpected in API Development
Alesia Owens, Project Manager
Posted: September 12, 2018
Alesia Owens, Project Manager at PCI Synthesis talks about API Manufacturing from a project managers perspective.
Related posts:
How to Stem the Flow of Tainted Generic Drugs and Product Recalls
Easing Process Validation Rules for Small-Volume Manufacturers
Transferring API Technology to a CMO? Use This Checklist
Manufacturing Generic Versions of Controlled Substances
Eight Considerations to Reduce the Cost of Success in API Manufacturing
About the Author
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...